Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA

International Journal of Hyperthermia

Volumn 29, Issue 5, 2013, Pages 480-490

  Dayanc, Baris E ^a,c   Bansal, Sanjay ^a,d   Gure, Ali Osmay ^b   Gollnick, Sandra O ^a   Repasky, Elizabeth A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b BILKENT UNIVERSITY   (Turkey)

^c INONU UNIVERSITY   (Turkey)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cytotoxicity; Fever range hyperthermia; HSF 1; MICA; Natural killer cells; NKG2D

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; LUCIFERASE; MEMBRANE PROTEIN; MICA PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; COLON CANCER; CYTOTOXICITY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TEMPERATURE STRESS; THERMOREGULATION; TUMOR XENOGRAFT; UPREGULATION;

EID: 84881146381     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.821526     Document Type: Article

References (52)

1. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975;16:230-9.
2. Kiessling R, Klein E, Wigzell H. 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112-17.
3. Glimcher L, Shen FW, Cantor H. Identification of a cell-surface antigen selectively expressed on the natural killer cell. J Exp Med 1977;145:1-9. (Pubitemid 8010087)
4. Gryllis C, Wainberg MA, Bentwich Z, Gornitsky M, Brenner BG. Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals. Clin Exp Immunol 1992;89:356-61.
5. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193: 661-70. (Pubitemid 32524460)
6. Garner WL, Minton JP, James AG, Hoffmann C. Human breast cancer and impaired NK cell function. J Surg Oncol 1983;24:64-6. (Pubitemid 13004154)
7. Kobayashi H, Sigrid Dubois, Noriko Sato, Helen Sabzevari, Yoshio Sakai, Waldman TA, et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 2005;105:721-7. (Pubitemid 40070758)
8. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597-604. (Pubitemid 23218208)
9. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-9. (Pubitemid 28099678)
10. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19: 197-223. (Pubitemid 32368034)
11. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 1999;285:727-9.
12. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998;161:571-7. (Pubitemid 28323516)
13. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993;151:60-70. (Pubitemid 23206971)
14. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4: 573-81. (Pubitemid 26233311)
15. Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, et al. NTB-A [correction of GNTB-A], a novel SH2D1Aassociated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001;194:235-46. (Pubitemid 32730798)
16. Lopez-Botet M, Carretero M, Bellón T, Pérez-Villar JJ, Llano M, Navarro F. The CD94/NKG2C-type lectin receptor complex in recognition of HLA class I molecules. Res Immunol 1997;148: 155-9. (Pubitemid 27304410)
17. Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, et al. Killer cell inhibitory receptors: Diversity, specificity, and function. Immunol Rev 1997;155:135-44. (Pubitemid 27076065)
18. Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008;24:41-56. (Pubitemid 351167618)
19. Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA. Enhancement of natural killer (NK) cell cytotoxicity by feverrange thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007;82: 1322-31. (Pubitemid 350133530)
20. Bahram S, Inoko H, Shiina T, Radosavljevic M. MIC and other NKG2D ligands: From none to too many. Curr Opin Immunol 2005;17:505-9. (Pubitemid 41207954)
21. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93:12445-50. (Pubitemid 26367163)
22. Borchers MT, Harris NL, Wesselkamper SC, Vitucci M, Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006;291: L222-31. (Pubitemid 44148106)
23. Gannage M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L, et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease. Transplantation 2008;85:911-15. (Pubitemid 351440760)
24. Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, et al. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 2005;65:6321-9. (Pubitemid 40994418)
25. Boissel N, Rea D, Tieng V, Dulphy N, Brun M, Cayuela JM, et al. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol 2006;176:5108-16.
26. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 2007;110: 606-15. (Pubitemid 47105399)
27. Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol 2006;67:159-69. (Pubitemid 43673921)
28. Kato N, Tanaka J, Sugita J, Toubai T, Miura Y, Ibata M, et al. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2Dexpressing cells. Leukemia 2007;21:2103-8. (Pubitemid 47423800)
29. Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, et al. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol 2004;173:5583-90. (Pubitemid 39392145)
30. Rodriguez-Rodero S, González S, Rodrigo L, Fernández-Morera JL, Martínez-Borra J, López-Vázquez A, et al. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007;37:1938-53. (Pubitemid 47065130)
31. Skov S, Pedersen, MT, Andresen L, Straten PT, Woetmann A, Odum N. Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class Irelated chain A and B. Cancer Res 2005;65:11136-45. (Pubitemid 41713385)
32. Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol 2007;178:961-9. (Pubitemid 46095169)
33. Schreiner B, Voss J, Wischhusen J, Dombrowski Y, Steinle A, Lochmuller H, et al. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. Faseb J 2006;20: 118-20. (Pubitemid 43100486)
34. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003; 104:354-61. (Pubitemid 36249818)
35. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003;171: 5423-9. (Pubitemid 37432829)
36. Pritchard MT, Ostberg JR, Evans SS, Burd R, Kraybill W, Bull JM, et al. Protocols for simulating the thermal component of fever: Preclinical and clinical experience. Methods 2004;32:54-62. (Pubitemid 37421181)
37. Sistonen L, Sarge KD, Morimoto R. Human heat shock factors 1 and 2 are differentially activated and can synergistically induce hsp70 gene transcription. Mol Cell Biol 1994;14:2087-99. (Pubitemid 24074606)
38. Fionda C, Soriani A, Malgarini G, Iannitto ML, Santoni A, Cippitelli M. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. J Immunol 2009;183:4385-94.
39. Murapa P, Gandhapudi S, Skaggs HS, Sarge KD, Woodward JG. Physiological fever temperature induces a protective stress response in T lymphocytes mediated by heat shock factor-1 (HSF1). J Immunol 2007;179:8305-12.
40. Mohammadpour HA. Isolation and culture of human colon epithelial cells using a modified explant technique employing a noninjurious approach. Methods Mol Med 2005;107:237-47.
41. Burd R, Dziedzic ST, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998;177: 137-47. (Pubitemid 28421530)
42. Loo DT, Rillema JR. Measurement of cell death. Methods Cell Biol 1998;57:251-64. (Pubitemid 128787444)
43. Tomasello E, Yessaad N, Gregoire E, Hudspeth K, Luci C, Mavilio D, et al. Mapping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues. Front Immunol 2012;3:344.
44. Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 2007;447:482-6. (Pubitemid 46816733)
45. Salih HR, Rammensee HG, Steinle A. Cutting edge: ownregulation of MICA on human tumors by proteolytic shedding. J Immunol 2002;169:4098-102. (Pubitemid 35178177)
46. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11: 237-44. (Pubitemid 20198988)
47. Gorelik E, Gunji Y, Herberman RB. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity. J Immunol 1988;140:2096-102.
48. Perera L, Shao L, Patel A, Evans K, Meresse B, Blumberg R, et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis 2007;13:298-307. (Pubitemid 46465911)
49. Lin D, Lavender H, Soilleux EJ, O'Callaghan CA. NF-kappaB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem 2012;287: 4299-310.
50. Andresen L, Jensen H, Pedersen MT, Hansen KA, Skov S. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J Immunol 2007;179:8235-42.
51. Luo L, Lu J, Wei L, Long D, Guo JY, Shan J, et al. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010;11:91.
52. Bedel R, Thiery-Vuillemin A, Grandclement C, Balland J, Remy-Martin JP, Kantelip B, et al. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Cancer Res 2011;71: 1615-26.